Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_Display\ Name in Display Name (approximate match)

Showing 2151 - 2160 of 2492 results

First page
Previous page
Next page
Next page

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

U6C4GJ6WZG

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84ab20c2-ebc1-4118-8615-50621b0ba9e9

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

9A68J3T9TE

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

MHG4XW7BIG

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

BJ5KGE8QEP

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2006)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dccfb747-8f64-46ec-3993-95195b585581

First approved in 2006

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dccfb747-8f64-46ec-3993-95195b585581

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

A5PTS27URJ

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2006)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dccfb747-8f64-46ec-3993-95195b585581

First approved in 2006

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dccfb747-8f64-46ec-3993-95195b585581

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN

236YGP181O

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN

25VC15141Q

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN

L1977Q86S5

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN

6334XMP4KC

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN

JU499IS53H

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN

Showing 2151 - 2160 of 2492 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1